Penicillin V API
Bacterial Infections
CommercialActive
Key Facts
About Biotika
Biotika is a long-established European API manufacturer with over 70 years of operational history, headquartered in Bratislava, Slovakia. Its core business is the biotechnological fermentation and production of established antibiotic APIs, specifically penicillin V and polymyxin B sulfate, which it exports globally. The company complements its proprietary manufacturing with contract development and manufacturing organization (CDMO) services, focusing on scale-up and process optimization for biotechnological products. Operating under stringent EU (EMA) and US (FDA) GMP standards, Biotika is a specialized, revenue-generating player in the generic antibiotic and niche anti-infective supply chain.
View full company profileTherapeutic Areas
Other Bacterial Infections Drugs
| Drug | Company | Phase |
|---|---|---|
| Azithromycin Preparations | cspc-pharmaceutical | Commercial |
| Penem Preparations | cspc-pharmaceutical | Commercial |
| Various Penicillin/Cephalosporin Products | cspc-pharmaceutical | Commercial |
| Nemonoxacin Malate Capsules | Zhejiang Medicine | Commercial |
| Generic Portfolio Expansion - Anti-infectives | Alkaloid AD Skopje | Regulatory Submission |
| Clindamycin Phosphate Injection | Viwit | Commercial |
| Levofloxacin Hydrochloride Injection | Viwit | Commercial |
| Meropenem-Vaborbactam | SciClone Pharmaceuticals | Commercial (in China) |
| Vibativ® (telavancin) | Cleo Life Sciences | Approved |
| Sterile Injectable Antibiotics Portfolio | Steripharma | Approved |
| Oral Antibiotic | Dawah Pharmaceuticals | ANDA Filed/Pre-approval |
| XAB05/XAB06 | Xenothera | Preclinical |